Bone marrow-derived mononuclear cells (BM-MNCs)

· Oregon Health & Science University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bone marrow-derived mononuclear cells (BM-MNCs), covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: BM-MNCs for Lower Extremity Compartment Syndrome Injury [Phase 1]